Martin Tami Tillotson Insider Trades

Insider Trading History

Track insider trading activity for Martin Tami Tillotson. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $3.83M 86,933 shares
Last Trade
Feb 23, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.1k 485 shares
$29.06
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $165k 3,750 shares
Last Trade
Feb 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$36.3k 1,250 shares
$29.06
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $3.85M 87,418 shares
Last Trade
Feb 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.3k 1,250 shares
$29.06
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $3.79M 86,168 shares
Last Trade
Feb 22, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.87k 246 shares
$27.94
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $3.81M 86,414 shares
Last Trade
Feb 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21k 750 shares
$27.94
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $66.1k 1,500 shares
Last Trade
Feb 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$21k 750 shares
$27.94
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $0 0 shares
Last Trade
Jan 10, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$225k 8,000 shares
$28.14
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $4.12M 93,664 shares
Last Trade
Jan 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$225k 8,000 shares
$28.14
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $3.77M 85,664 shares
Last Trade
Jan 10, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$223k 8,000 shares
$27.91
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $4.11M 93,349 shares
Last Trade
Aug 30, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$259k 8,100 shares
$31.97
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $612k 13,900 shares
Last Trade
Aug 30, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$259k 8,100 shares
$31.97
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $3.75M 85,249 shares
Last Trade
Aug 30, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$259k 8,100 shares
$32.00
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $3.75M 85,249 shares
Last Trade
Aug 25, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$162k 5,135 shares
$31.59
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $881k 20,000 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$772k 20,000 shares
$38.60
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $3.98M 90,323 shares
Last Trade
Feb 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.9k 750 shares
$38.57
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $99.1k 2,250 shares
Last Trade
Feb 22, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$28.9k 750 shares
$38.57
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $3.96M 90,034 shares
Last Trade
Feb 22, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.1k 289 shares
$38.57
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $3.98M 90,323 shares
Last Trade
Feb 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.9k 750 shares
$38.57
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $99.1k 2,250 shares
Last Trade
Feb 22, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$28.9k 750 shares
$38.57
$44.04
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Sr. V.p., Regulatory Affairs
Holding Value $3.91M 88,720 shares
Last Trade
Feb 16, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$58k 1,500 shares
$38.65
$44.04

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up